Çaliş Karanfil

As seen in: Anti-Cancer Drugs

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Çaliş

Contact Çaliş, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Articles

Varied toxicity profile of intravitreal melphalan in two... : Anti-Cancer Drugs

Oct 08, 2024 |

By Çaliş Karanfil, Ahmet Kaan

| Anti-Cancer Drugs

Your message has been successfully sent to your colleague. Some error has occurred while processing your request. Please try after some time. End Note Procite Reference Manager Save my selection

Open in Who Shared View Duplicates (64)

See all 2 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Get in touch with Çaliş

Contact Çaliş, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

For PR Teams

Overview

Use Cases

Capabilities

Industries

Introducing Curation Engine

Resources

Library

Commmunity

Customers

Company

Çaliş Karanfil

Get in touch with Çaliş

Actions

Is this you?

Articles

Varied toxicity profile of intravitreal melphalan in two... : Anti-Cancer Drugs

Actions

Is this you?

Get in touch with Çaliş